drugset / Trial / NCT00945009

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

NCT00945009

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This phase III trial studies how well combination chemotherapy and surgery work in treating young patients with Wilms tumor. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving it after surgery may kill any tumor cells that remain after surgery.

Timeline

Start
2009-08-24
Primary completion
2016-12-31
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dactinomycin Protein / enzyme biologic Intravenous
Subject Doxorubicin Other / unclassified Intravenous
Subject Vincristine Small molecule Intravenous